Relative Bioavailability For Palbociclib Formulations
NCT02083640
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Palbociclib Formulation Reference
DRUG:
Palbociclib Formulation Test
DRUG:
Palbociclib Formulation Test
Sponsor
Pfizer